Ardelyx (ARDX) Cash from Operations (2013 - 2026)
Ardelyx (ARDX) posted Cash from Operations of 32237000.0 for Q1 2026, down 253.87% on a QoQ basis from 20951000.0 in Q4 2025, and up 16.17% year-over-year from 27748915.75 in Q1 2025.
Ardelyx (ARDX) Cash from Operations (2013 - 2026) Analysis & Trends
Ardelyx's Cash from Operations history runs 14 years deep, the most recent figure standing at 32237000.0 for Q1 2026.
- Quarterly Cash from Operations rose 16.17% year-over-year to 32237000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36263000.0 (up 23.73% YoY) and the FY2025 annual result came in at 42483000.0, up 5.19% from the prior year.
- Cash from Operations was 32237000.0 for Q1 2026 at Ardelyx, down from 20951000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 20951000.0 in Q4 2025 and bottomed at 44795000.0 in Q1 2023.
- A 5-year average of 16428823.53 and a median of 21467000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations sank 161.03% — and 2024, when it jumped 212.53%.
- Ardelyx's Cash from Operations stood at 14284000.0 in 2022, then plunged by 161.03% to 8718000.0 in 2023, then soared by 212.53% to 9810000.0 in 2024, then soared by 113.57% to 20951000.0 in 2025, then tumbled by 253.87% to 32237000.0 in 2026.
- Business Quant data shows ARDX's Cash from Operations at 32237000.0 in Q1 2026, 20951000.0 in Q4 2025, and 365000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | -32.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.24 Mn |
| Mar 31, 2026 | -32.24 Mn |
| Dec 31, 2025 | 20.95 Mn |
| Dec 31, 2025 | 20.95 Mn |
| Sep 30, 2025 | 365,000.00 |
| Sep 30, 2025 | 365,000.00 |
| Jun 30, 2025 | -25.34 Mn |
| Jun 30, 2025 | -25.34 Mn |
| Mar 31, 2025 | -38.46 Mn |
| Mar 31, 2025 | -38.46 Mn |
| Dec 31, 2024 | 9.81 Mn |
| Dec 31, 2024 | 9.81 Mn |
| Sep 30, 2024 | 501,000.00 |
| Sep 30, 2024 | 501,000.00 |
| Jun 30, 2024 | -19.40 Mn |
| Jun 30, 2024 | -19.40 Mn |
| Mar 31, 2024 | -35.72 Mn |
| Mar 31, 2024 | -35.72 Mn |
| Dec 31, 2023 | -8.72 Mn |
| Dec 31, 2023 | -8.72 Mn |